Viking Therapeutics Rockets Skyward: Is Their Obesity Drug the Next Market Game-Changer? The Weight-Loss Gold Rush: Why All Eyes Are On Viking Therapeutics After a Hefty Biotech Deal Viking Therapeutics Nears Major Milestone for Game-Changing Oral Obesity Pill Roche's Strategic Investment Ignites Excitement in the MASH Drug Development Landscape